EUVIMEDEUVIMED entdecken
Crossref

Group 1 ILC are dynamically regulated during in hepatocellular carcinogenesis

G. Wiedemann, R. Schenk, K. Schmid, K. Pistrenko, L. Staufer, K. Engel, S. Große Wiesmann, M. Laschinger, D. Hartmann, N. Hüser, R. Schmid

Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e731

DOI: 10.1055/s-0044-1789909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von G. Wiedemann und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In hepatocellular carcinoma (HCC), tumorigenesis, tumor progression and prognosis are highly dependent on the immune system and novel therapeutic approaches like immune checkpoint blockade (ICB) therefore aim to harness the anti-tumoral immune response. Despite good responses in some patients, inhibitory signals within the tumor microenvironment (TME) impede therapeutic success in many patients. Group 1 innate lymphoid cells (ILC), consisting of natural killer cells (NK cells) and tissue-resident ILC1, comprise up to 40% of the liver lymphocyte infiltrate and play a central role in liver pathologies and cancerogenesis. NK cells are potently cytotoxic and have been shown to play a protective role in HCC, whereas the exact role of ILC1 is still poorly defined. Both cell types, however, are major contributors to the local immune response and are targeted by ICB therapy. In order to improve immunotherapeutic success, it is crucial to understand how NK cells and ILC1 are regulated within the HCC TME.

Aims

We aim to investigate how the changing microenvironments during hepatocarcinogenesis affect group 1 ILC phenotype and functionality.

Methods

In a mouse model of liver carcinogenesis, group 1 ILC were analyzed longitudinally via multi-color flow cytometry, single-cell RNA-sequencing, ATAC-sequencing and functional assays. Additionally, group 1 ILC from HCC patients’ peripheral blood, tumor and liver tissues were characterized.

Results

Liver carcinogenesis is accompanied by significant changes in group 1 ILC composition, phenotype and functionality. Both NK cells and ILC1 were enriched in tumor-bearing livers. Unexpectedly, the TME had diverging effects on group 1 ILC with ILC1 displaying an activated phenotype and increased degranulation. Analysis of transcriptomic and epigenetic changes in tumor-associated group 1 ILC identified central pathways of immune modulation within the TME.

Conclusion

Using high dimensionality flow cytometry, functional assays and multi-omics, we identified diverging microenvironmental effects on group 1 ILC in HCC tissues. Our findings will contribute to a better understanding of how the TME shapes immune cell functions in HCC. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Wiedemann, G., Schenk, R., Schmid, K., Pistrenko, K., Staufer, L., Engel, K., Wiesmann, S. G., Laschinger, M., Hartmann, D., Hüser, N., & Schmid, R. (2024). Group 1 ILC are dynamically regulated during in hepatocellular carcinogenesis. Zeitschrift für Gastroenterologie, 62(09), e731. https://doi.org/10.1055/s-0044-1789909

Vancouver

Wiedemann G, Schenk R, Schmid K, Pistrenko K, Staufer L, Engel K, et al. Group 1 ILC are dynamically regulated during in hepatocellular carcinogenesis. Zeitschrift für Gastroenterologie. 2024;62(09):e731. doi:10.1055/s-0044-1789909

BibTeX
@article{Wiedemann2024,
  author = {Wiedemann, G. and Schenk, R. and Schmid, K. and Pistrenko, K. and Staufer, L. and Engel, K. and Wiesmann, S. Große and Laschinger, M. and Hartmann, D. and Hüser, N. and Schmid, R.},
  title = {Group 1 ILC are dynamically regulated during in hepatocellular carcinogenesis},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {09},
  pages = {e731},
  doi = {10.1055/s-0044-1789909}
}
Kostenlos starten →